Position in MRK
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$12,248,234
+$1,061,986 QoQ
Shares Held
95,317
+2.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#669
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. MRK ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,248,234 | 95,317 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $11,186,248 | 92,994 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $11,217,452 | 106,569 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,124,507 | 96,801 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $8,496,559 | 107,334 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $11,252,762 | 125,365 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,901,858 | 19,118 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,556,812 | 31,321 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $10,266,238 | 82,926 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $11,205,194 | 84,920 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $8,194,924 | 75,169 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $6,437,257 | 62,528 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,261,644 | 19,600 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,020,346 | 18,990 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,169,707 | 55,608 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,310,736 | 50,055 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,849,926 | 42,228 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,464,971 | 42,230 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,441,519 | 44,905 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,332,691 | 31,057 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,404,337 | 30,916 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,913,244 | 50,762 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $3,790,610 | 46,340 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,855,849 | 46,484 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $726,824 | 9,399 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $605,594 | 7,871 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||